SCM
HZNP

Sio Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Sio Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-40,000
Closed -$3.19M – 71
2022
Q2 		$3.19M Buy
+40,000
New +$3.79M 1.26% 25
2022
Q1 		– Sell
-29,319
Closed -$3.16M – 92
2021
Q4 		$3.16M Hold
29,319
– – 0.96% 28
2021
Q3 		$3.21M Sell
29,319
-38,152
-57% -$3.96M 1.04% 32
2021
Q2 		$6.32M Buy
67,471
+2,670
+4% +$246K 1.71% 18
2021
Q1 		$5.96M Sell
64,801
-34,100
-34% -$2.88M 1.25% 29
2020
Q4 		$7.24M Sell
98,901
-48,599
-33% -$3.61M 1.58% 21
2020
Q3 		$11.5M Buy
+147,500
New +$10.1M 2.54% 16

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return